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Nuclear medicine training in the European Union
Nuclear Medicine (NM) became an independent medical
specialty in the European Directives in 1988. The minimum
duration of the postgraduate specialized training in the
European Union is 4 years, but may be extended beyond
this period according to the requirements of training in
other clinical disciplines.
Candidates for specialized training should have a good
general background in internal medicine. More detailed
knowledge has to be acquired of those conditions which
may need to be investigated or treated by NM techniques,
as well as of some complementary methods as far as they
relate to NM procedures. Training in basic sciences is
required, such as pharmacokinetics, radiochemistry, instru-
mentation, computer science and quality control.
The quality of training has to be objectively assessed,
using final examination on a national basis covering basic
sciences and clinical skills, after satisfactory completion of a
minimum number of courses and/or workshops and a
formally organized and controlled practical training. Each
training programme should contain a standard against which
the progress of the trainee can be assessed for each element
of the syllabus. The assessment may take the form of an
interview, a written paper, an essay, a set of multiple-choice
questions, or an oral examination of displayed images of
various NM techniques in clinical practice. Continuous
assessment is another alternative. Each end of year assess-
ment should carry a score that indicates how the candidate
has progressed against the set target. Successful trainees are
awarded with a final certificate, degree or diploma that is
recognized by the government, local health authority and
hospital as an assurance of specialist competence in NM.
The clinical training of physicians specializing in NM
should include: 1) a minimal theoretical foundation of the
general principles of NM with active participation in
clinical presentations, seminars and meetings and 2) in
vivo diagnostic procedures. Personal responsibility (includ-
ing indication, performance and interpretation) must be
taken for at least 3.000 in vivo NM diagnostic procedures,
with a broad-spectrum of the most currently used proce-
dures. The list of the procedures published in the syllabus
will be subject to revision. It is recommended that a period
of training be spent away from the main department in at
least one other recognized centre. In addition the training
should cover therapy with unsealed radioactive sources.
The trainee must have taken part in a sufficient number of
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various NM therapeutic procedures. The responsibilities of
the NM specialists are listed in Table 1.
I. Scope and limits of the medical specialty of Nuclear
Medicine
1. Definition (scope):
NM utilizes the nuclear properties of matter to
investigate disorders of metabolism and function,
of physiology and pathophysiology, and of anato-
my to diagnose and treat disease with unsealed
sources of radioactivity. The range of procedures
that are implicit within this definition include in
vitro procedures, in vivo imaging with radiophar-
maceuticals and other techniques related to nuclear
physics in medicine as well as the medical
applications of radiobiology, dosimetry and radia-
tion protection.
2. Clinical knowledge and experience:
A good general background in medicine (internal
medicine, surgery) is assumed. More detailed knowl-
edge is required of those conditions which may need
to be investigated or treated by NM techniques.
3. NM may also make use of complementary methods
related to NM procedures. These include:
– Ultrasound
– ECG (including dynamic + pharmacological stress
testing) and management of emergencies in cardiac
NM
– Fine-needle biopsy
– Quantitative imaging: MRI, MRS, and correlative
imaging methods (including CT)
– Spirometry
– Non-radioactive laboratory assays
– Bone densitometry
– Other available techniques complementary to NM
procedures
– CT for attenuation correction and anatomic
localization
4. NM specialists may cooperate in the assessment,
prevention and treatment of physical or medical
accidental contamination or incorporation of
radionuclides.
II. Formative objectives
1. Basic theoretical formative objectives:
– Mathematics and physics, including radiation phys-
ics and statistics
– Informatics
– Kinetic modeling
– Imaging processing
– Instrumentation
– Interaction between radiation and biological structures
– Radiobiology
– Radiation protection and radiopathology
– Physiology and pathophysiology
– Clinical radiopharmacology
2. Specific theoretical formative objectives:
– Evaluation and statistics of radioactive counting
– Radiochemistry, radiopharmacy and quality control
of radiopharmaceuticals
– Radionuclide labeling of cells, sub cellular struc-
tures and biological molecules
– Applications of radiotracers: indications, proce-
dures and results, methodology and dosimetry
– Data acquisition and processing techniques for
imaging treatment, including SPECT and PET
– Integration and evaluation of the diagnostic results
with the clinical data and the results of other
procedures
– Radiation protection
3. Integrative objectives:
– Radiopharmaceutical preparation
– Radiopharmaceutical administration to the patients
– Diagnostic imaging methodology in vivo for dif-
ferent organs and systems
– Study of neoplastic and non-neoplastic pathological
processeswith radionuclides and radiopharmaceuticals
in vivo
– Application of radionuclide therapy to neoplastic
and non-neoplastic pathological processes
– Principles and applications of radioimmunological
and immunoradiometric techniques in vitro
– Principles of other diagnostic imaging techniques
(including ultrasonography, CT, MRI, digital
radiology)
– Integration and interpretation of the results of the
NM procedures with those of radiodiagnostic
methods, with particular attention to fusion imag-
ing modalities
Table 1 Responsibilities of the nuclear medicine specialist
Define the patient’s and clinician’s rationale for the request or referral
Determine and organize the appropriate tests and protocols
Adapt the protocols to the needs and condition of the patient
Assess and accomplish interventions (physiological, pharmacological
or mental stress related)
Regulate the study analysis and interpretation according
to the clinical information
Interpret the results and their clinical, biological and pathological
implications
Consider follow-up consultations
Guarantee the safety of both the patient and staff
Provide training and education for junior doctors and technical staff
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– Basic principles of scientific research methodology
– Organization and management of a NM service and
basic methodology for programming scientific
research
– Study of the legislation related to the transportation,
storage, disposal and use of radioactive material
III. Basic sciences training (Syllabus)
This section provides an indication of training for each
of the four years:
Year 1 (a) Scientific principles:
– Basic physics and mathematics;
– Instrumentation;
– Principles of computer science;
– Basic radiation biology and radiation protection;
– Basic radiopharmacy and radiochemistry;
– Principles of tracer technology.
(b) Clinical NM:
– Diagnostic imaging: mode of pharmaceutical uptake;
normal and abnormal appearances of images, normal
variants and common artifacts in bone, heart, lung,
kidney, brain, thyroid, tumor and infection images.
– Therapeutic applications: basic principles of radio-
nuclide therapy; treatment of hyperthyroidism,
thyroid cancer and metastatic bone pain.
– Principles of radiation protection: ALARA (as low
as reasonably achievable), ALARP (as low as
reasonably practicable).
– Diagnosis and treatment of thyroid diseases.
Year 2 (a) Requirements of Year 1 in greater depth:
– Tracer kinetics;
– Computing and image processing;
– Radiobiology including the biological effects of
high and low levels of radiation;
– Linear hypothesis and the threshold hypothesis of
the biological response to low level radiation;
– The effective dose equivalent and the calculation of
radiation dose from radiopharmaceuticals.
(b) Radiopharmacy:
– Properties of commonly used diagnostic and
therapeutic radiopharmaceuticals;
– Production of radionuclides by reactors, cyclotrons
and radionuclide generators;
– Quality assurance and quality control of
radiopharmaceuticals.
Year 3 (a) Requirements of Year 2 in greater depth:
– Principles of radiology including dual energy X ray
absorption (DEXA), ultrasound, CT and MRI
imaging;
– Learning of cross-sectional anatomy;
– Correlative imaging of NM images and those from
other imaging techniques;
– Special diagnostic investigations in cardiology, lung
disease, gastroenterology, hepatobiliary diseases,
nephro-urology, neurology and psychiatry, endocri-
nology, hematology, oncology and infection.
(b) Therapeutic applications:
– Treatment of bone metastases, neuroendocrine
tumours and other malignancies as well as
polycythemia,;
– Use of radiolabeled monoclonal antibodies and
peptides for tumor therapy.
Year 4 Further practice and experience of techniques
learned in years 1–3:
– Ethics;
– Legal and regulatory requirements;
– Audit;
– Departmental and hospital management;
– Research techniques and evaluation;
– Teaching and training.
The quality of the basic science training has to be
objectively assessed, using the following methods:
1. Final examination (covering basic science and clinical
knowledge) on national basis and/or
2. Satisfactory completion of accredited, regional or
national (international) courses or workshops in differ-
ent fields (physics etc.): 120 hours recommended.
Radiation protection and regulatory issues have to obey
local/national requirements.
IV. Clinical training in NM
A clinical training has to be added to the courses
and has to be formally controlled. The clinical training
of physicians specializing in NM should include
theoretical and practical training within and outside of
the NM Department. Minimum standards are indicated
here.
1. Theoretical founding in NM
A minimum of 30 hours of formal description of
general principles of NM procedures is required. Active
participation in clinical presentations, seminars and
meetings is recommended.
2. Practical training in NM
Postgraduate trainees are obliged to play an active in-
service role in the practice of NM in order to
familiarize themselves with all the techniques required
of a NM practitioner, such as:
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– Protocols of in vivo and therapeutic procedures;
– Data acquisition and processing with various types
of equipment, quality control of instruments and
labeled agents;
– Interventional procedures, including physiolog-
ical, pharmacological and mental stress related
for diagnostic applications, and all therapeutic
interventions;
– In vitro protocols and procedures, as appropriate.
3. In vivo diagnostic procedures
At the end of the training program, postgraduate
trainees must be capable to plan, perform, report and
archive diagnostic procedures in vivo related to the
following clinical areas:
– Central nervous system
– Bone and joints
– Cardiovascular system
– Respiratory system
– Gastrointestinal system
– Urinary and genital system
– Endocrine system
– Haematopoetic and lymphatic system
– Neoplastic processes
– Inflammatory and degenerative processes
The trainee must reach a total of 3,000 documented
diagnostic procedures. The minimum recommended num-
ber for each procedure is as follows:
a) Central nervous system 100 (80% SPET or PET)
b) Bone and joints 600
c) Cardiovascular system 500 (80% SPET or PET)
d) Respiratory system 300 (50% combined V/Q)
e) Gastrointestinal system 50
f) Urinary and genital system 400
g) Endocrine system 400
h) Haematopoetic and lymphatic system 50
i) Neoplastic processes 550 (80% SPET, PET or
SPET/CT, PET/CT)
j) Inflammatory and degenerative processes 50
It is recommended that at least 100 procedures have been
performed in pediatric patients. Some flexibility may be
accepted, but a broad-spectrum of most currently used
procedures has to be covered. This list will be subject to
periodic revision. It is recommended that a period of
training is spent away from the main department in at
least one other recognized training centre.
4. Clinical training in addition to NM
Clinical bedside training in a clinical specialty is
required before or during specialist training. A limited
period of 6 months in diagnostic radiology or clinical
physiology may replace a clinical bedside semester.
The proportion of the total training period devoted to
clinical training and to NM may vary according to
various factors, among them the total length of the
training. The minimum advisable duration of training is
5 years. In some countries total duration of the
specialized training is 4 years (which corresponds to
the minimum duration in the Directive of the EC). In
any case a minimum of 3 years should be devoted to
NM exclusively and 1 year to other specialties. In
countries where part of the requested training is
provided during rotation in other departments it must
be made sure that all requirements of the syllabus are
fulfilled.
5. In vitro procedures
Training can also cover in vitro procedures including
analysis with (radio-)immunological methods, quality
control and interpretation, with a recommended mini-
mum duration of 3 months.
6. Therapy
Training should include indication, administration, and
therapeutic applications of radionuclides, dosimetry,
radiation protection and follow-up after therapy.
The trainee must have taken part in 100 various NM
therapeutic procedures.
7. Clinical audit
The trainee should have received education in audit of
clinical NM and in the administration and financing of
a NM Service.
8. Function as expert
The trainee must acquire legal expertise in health care
problems related with unsealed radionuclides.
V. Assessment of training in NM
Since trainees will take over the responsibilities of a
nuclear physician, they must pass a qualifying test that
covers both theoretical knowledge and practical abili-
ties in the daily practice of NM. A board or similar
form of authority will award a certificate to successful
trainees.
Appendix
The aim of the syllabus is to set standards, made of
duration and content (qualitative and quantitative, practical
and theoretical) of training in nuclear medicine. These
essential requirements can be adapted to local practice and
necessities to fit the specific situation of each country. The
content of the syllabus also represents the standard for
accreditation of training centres and the basis of the
Fellowship exam.
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